$4.05
0.041.00%
At Close: -
$3.82
-0.23-5.66%
After Hours: Aug 21, 4:01 PM EDT
15 minutes delayed
Scinai Immunotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Scinai Immunotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-11 | $-1.20 | $-0.91 | -31.9 % |
Mar 2023 | 2023-05-15 | $-1.20 | $-0.73 | -64.4 % |
Mar 2023 | 2023-04-17 | $0 | $-0.10 | 100.0 % |
Sep 2022 | 2022-11-30 | $0.06 | $-0.10 | 160.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Scinai Immunotherapeutics (SCNI) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on August 15, 2024 for Q2.
The Actual EPS was $-4.00, which missed the estimate of $0.00.
The Actual Revenue was $284K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.